Nobel prize-winning Treg cells in autoimmune kidney diseases and transplantation.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 41864664.
- Also identified by DOI 10.1016/j.kint.2026.01.005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their research into mechanisms by which the immune system avoids attacking the body's own tissues. At the heart of this research was the discovery of the regulatory T cell, a peculiar immune cell with the capacity to shut down autoimmunity. This Editorial: Special Report looks at the tenacious science and scientists behind the discovery of the regulatory T cell, and the clinical progress of regulatory T-cell therapies to treat autoimmune kidney diseases and transplant rejection.
Medical subject headings
- Nobel Prize
- T-Lymphocytes, Regulatory
- Kidney Transplantation
- Graft Rejection
- Autoimmune Diseases
- Autoimmunity
- Kidney Diseases